Promoting walking and cycling proposes solutions to one of the most pressing problems in contemporary British transport planning. The need to develop more sustainable urban mobility lies at the heart of energy and environmental policies and has major implications for the planning of cities and for the structure of economy and society. However, most people feel either unable or unwilling to incorporate travel on foot or by bike into their everyday journeys. This book uses innovative quantitative and qualitative research methods to examine in depth, and in an international and historical context, why so many people fail to travel in ways that are deemed by most to be desirable. It proposes evidence-based policy solutions that could increase levels of walking and cycling substantially. This book is essential reading for planners and policy makers who are developing and implementing transport policies at both national and local levels, plus researchers and students in the fields of mobility, transport, sustainability and urban planning.

This volume maps the areas of ethical concern in the debate regarding the governance of genetic information, and suggests alternative ethical frameworks and models of regulation in order to inform its restructuring. Genetic governance is at the heart of medical and scientific developments, and is connected to global exploitation, issues of commodification, commercialisation and ownership, the concepts of property and intellectual property and concerns about individual and communal identity. Thus the decisions that are made in the next few years about appropriate models of genetic governance will have knock-on effects for other areas of governance. In short the final answer to 'Who Decides?' in the context of genetic governance will fundamentally shape the ethical constructs of individuals and their networks and relationships in the public sphere.

This volume maps the areas of ethical concern in the debate regarding the governance of genetic information, and suggests alternative ethical frameworks and models of regulation in order to inform its restructuring. Genetic governance is at the heart of medical and scientific developments, and is connected to global exploitation, issues of commodification, commercialisation and ownership, the concepts of property and intellectual property and concerns about individual and communal identity. Thus the decisions that are made in the next few years about appropriate models of genetic governance will have knock-on effects for other areas of governance. In short the final answer to 'Who Decides?' in the context of genetic governance will fundamentally shape the ethical constructs of individuals and their networks and relationships in the public sphere.